Nuvectis Pharma Ownership | Who Owns Nuvectis Pharma?


OverviewFinancialsChart

Nuvectis Pharma Ownership Summary


Nuvectis Pharma is owned by 7.54% institutional investors, 44.38% insiders, and 48.08% retail investors. Baldwin brothers llc/ma is the largest institutional shareholder, holding 2.07% of NVCT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.99% of its assets in Nuvectis Pharma shares.

NVCT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNuvectis Pharma7.54%44.38%48.08%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baldwin brothers llc/ma355.96K2.07%$1.93M
Vanguard group325.30K1.89%$1.76M
Marshall wace, llp124.57K0.72%$673.93K
Blackrock83.41K0.50%$528.00K
Geode capital management79.24K0.46%$428.78K
Goldman sachs group61.57K0.37%$389.74K
Blackrock funding, inc. /de62.34K0.36%$337.27K
Forbes j m & co llp59.00K0.34%$319.19K
Northern trust49.83K0.30%$315.40K
Susquehanna group, llp45.61K0.26%$246.73K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Baldwin brothers llc/ma355.96K0.13%$1.93M
Forbes j m & co llp59.00K0.03%$319.19K
Gsa capital partners llp34.75K0.01%$188.00K
Baxter bros15.00K0.01%$81.15K
Point72 asia (singapore) pte.4.48K0.01%$24.23K
Nations financial group inc, /ia/ /adv13.50K0.01%$73.03K
Oppenheimer25.00K0.00%$135.25K
Edmond de rothschild15.17K0.00%$82.07K
Marshall wace, llp124.57K0.00%$673.93K
Qube research30.59K0.00%$165.51K

Top Buyers

HolderShares% AssetsChange
Baldwin brothers llc/ma355.96K0.13%181.83K
Marshall wace, llp124.57K0.00%81.76K
Goldman sachs group61.57K0.00%61.57K
Oppenheimer25.00K0.00%25.00K
Vanguard group325.30K-24.16K

Top Sellers

HolderShares% AssetsChange
Blackrock83.41K--289.31K
State street15.30K--114.08K
Iridian asset management llc/ct---55.38K
Millennium management29.70K0.00%-38.80K
Morgan stanley10.20K--30.99K

New Positions

HolderShares% AssetsChangeValue
Goldman sachs group61.57K0.00%61.57K$389.74K
Oppenheimer25.00K0.00%25.00K$135.25K
Squarepoint ops19.07K0.00%19.07K$103.17K
Citadel advisors14.94K-14.94K$94.55K
Cubist systematic strategies6.29K0.00%6.29K$34.05K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-1.00
Nbc securities-5.00
Nisa investment advisors-12.00
Gamma investing-25.00
Amalgamated bank-231.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202430-3.23%1,298,77823.77%720.32%2053.85%8-27.27%
Sep 30, 202431-18.42%1,049,389-12.85%611.52%14-44.00%11-
Jun 30, 202438-5.00%1,204,111-22.91%79.04%2513.64%11-
Mar 31, 20244011.11%1,561,9813.22%810.16%224.76%1183.33%
Dec 31, 2023369.09%1,513,31918.48%913.27%2140.00%6-53.85%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv231.04K0.99%-
Vanguard Institutional Extnd Mkt Idx Tr85.43K0.37%3.67K
Fidelity Extended Market Index36.12K0.15%-230.00
Extended Equity Market Fund K25.85K0.11%15.36K
NT R2000 Growth Index Fund - NL20.57K0.11%-
iShares Micro-Cap ETF21.07K0.09%-
NT R2000 Index Fund - NL13.99K0.07%-5.76K
The Vanguard Russell 2000 Growth Index12.03K0.06%-
NT R2000 Growth Index Fund - L11.40K0.06%-3.64K
Northern Trust Russell 2000 Growth Index11.40K0.06%-3.64K

Recent Insider Transactions


DateNameRoleActivityValue
Feb 07, 2025Mosseri Marlio Charles-Buy$1.20M
Dec 24, 2024BENTSUR RON Chairman & CEOBuy$20.93K
Dec 12, 2024Mosseri Marlio Charles-Buy$149.04K
Dec 13, 2024Mosseri Marlio Charles-Buy$79.90K
Dec 13, 2024Mosseri Marlio Charles-Buy$79.90K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q461
2024 Q3--
2024 Q24-
2024 Q11-

NVCT Ownership FAQ


Who Owns Nuvectis Pharma?

Nuvectis Pharma shareholders are primarily institutional investors at 7.54%, followed by 44.38% insiders and 48.08% retail investors. The average institutional ownership in Nuvectis Pharma's industry, Biotech Stocks , is 68.48%, which Nuvectis Pharma falls below.

Who owns the most shares of Nuvectis Pharma?

Nuvectis Pharma’s largest shareholders are Baldwin brothers llc/ma (355.96K shares, 2.07%), Vanguard group (325.3K shares, 1.89%), and Marshall wace, llp (124.57K shares, 0.72%). Together, they hold 4.68% of Nuvectis Pharma’s total shares outstanding.

Does Blackrock own Nuvectis Pharma?

Yes, BlackRock owns 0.50% of Nuvectis Pharma, totaling 83.41K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 528K$. In the last quarter, BlackRock decreased its holdings by -289K shares, a -77.62% change.

Who is Nuvectis Pharma’s biggest shareholder by percentage of total assets invested?

Baldwin brothers llc/ma is Nuvectis Pharma’s biggest shareholder by percentage of total assets invested, with 0.13% of its assets in 355.96K Nuvectis Pharma shares, valued at 1.93M$.

Who is the top mutual fund holder of Nuvectis Pharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Nuvectis Pharma shares, with 0.99% of its total shares outstanding invested in 231.04K Nuvectis Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools